GUINEVERE QUE: Open Payments
NPI 1821158783 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,977 in 157 payments from 30 companies in 2025. Trend: 2023 $6,218 · 2024 $1,750 · 2025 $2,977
Food & beverage: $2,977
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $654 |
| PFIZER INC. | 26 | $310 |
| Axsome Therapeutics, Inc. | 14 | $247 |
| Lilly USA, LLC | 9 | $169 |
| Lundbeck LLC | 12 | $166 |
| Biogen, Inc. | 9 | $146 |
| InSightec,Inc | 1 | $141 |
| Neurelis, Inc. | 6 | $111 |
| ARGENX US, INC. | 4 | $99 |
| Eisai Inc. | 4 | $83 |
Products named: QULIPTA, NURTEC ODT, LEQEMBI, Symbravo, VYEPTI, Exablate, UBRELVY, VALTOCO.
Industry payments across DC — which companies pay providers there.
